More

    Europe Markets

    Rozlytrek | European Medicines Agency (EMA)

    OverviewRozlytrek is a cancer medicine. It can be used for treating patients from 1 month of age with solid tumours (cancer growths) that...

    Contacts at the European Medicines Agency

    Contacts at the European Medicines Agency Source link

    EMA Management Board: highlights of March 2025 meeting

    Election of new Management Board ChairAt its March meeting, EMA’s Management Bord elected Rui Santos Ivo as new chair of the Board for...

    Naveruclif | European Medicines Agency (EMA)

    OverviewNaveruclif is used to treat the following cancers in adults:metastatic breast cancer, when the first treatment has stopped working and standard treatment including...

    Imraldi | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Imraldi. It explains how the Agency assessed the medicine to recommend...

    Zolsketil pegylated liposomal | European Medicines Agency (EMA)

    OverviewZolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other...

    Unregulated advanced therapy medicinal products pose serious risks to health

    EMA and the Heads of Medicines Agencies (HMA) are warning the public about the dangers of unregulated advanced therapy medicinal products (ATMPs) offered...

    Yselty | European Medicines Agency (EMA)

    OverviewYselty is a medicine used in adult women of childbearing age to treat:moderate to severe symptoms of uterine fibroids, which are non-cancerous (benign)...

    Sugammadex Mylan | European Medicines Agency (EMA)

    OverviewSugammadex Mylan is a medicine used to reverse the effect of the muscle relaxants rocuronium and vecuronium. Muscle relaxants are medicines used during...

    Evusheld | European Medicines Agency (EMA)

    OverviewEvusheld is a medicine used to prevent COVID-19 in adults and adolescents (from 12 years of age weighing at least 40 kilograms). It...

    Enerzair Breezhaler | European Medicines Agency (EMA)

    OverviewEnerzair Breezhaler is an asthma medicine for inhalation. It is used for maintenance (regular) treatment in adults whose asthma is not controlled well...

    Quofenix | European Medicines Agency (EMA)

    OverviewQuofenix is an antibiotic used in adults to treat:bacterial infections of the skin and underlying tissues (acute bacterial skin and skin structure infections);community-acquired...

    Sitagliptin / Metformin hydrochloride Mylan

    OverviewSitagliptin/Metformin hydrochloride Mylan is a medicine used to control blood glucose (sugar) levels in adults with type 2 diabetes. It is used together...

    Uzpruvo | European Medicines Agency (EMA)

    OverviewUzpruvo is a medicine used to treat:moderate to severe plaque psoriasis (a disease causing red, scaly patches on the skin). It is used...

    Silodosin Recordati | European Medicines Agency (EMA)

    OverviewSilodosin Recordati is a medicine used to treat the symptoms of benign prostatic hyperplasia (BPH, an enlarged prostate gland) in adults. The prostate...

    Dimethyl fumarate Accord | European Medicines Agency (EMA)

    OverviewDimethyl fumarate Accord is a medicine used to treat multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves...